These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11261512)

  • 1. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations.
    Portman AT; Giladi N; Leenders KL; Maguire P; Veenma-van der Duin L; Swart J; Pruim J; Simon ES; Hassin-Baer S; Korczyn AD
    Neurology; 2001 Jun; 56(12):1759-62. PubMed ID: 11425950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
    Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
    Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
    Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
    Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
    Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
    Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
    Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
    Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
    Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C
    Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
    Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
    Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.
    Klein C; Pramstaller PP; Kis B; Page CC; Kann M; Leung J; Woodward H; Castellan CC; Scherer M; Vieregge P; Breakefield XO; Kramer PL; Ozelius LJ
    Ann Neurol; 2000 Jul; 48(1):65-71. PubMed ID: 10894217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease.
    Varrone A; Pellecchia MT; Amboni M; Sansone V; Salvatore E; Ghezzi D; Garavaglia B; Brice A; Brunetti A; Bonavita V; De Michele G; Salvatore M; Pappatà S; Barone P
    Neurology; 2004 Dec; 63(11):2097-103. PubMed ID: 15596756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
    Scherfler C; Khan NL; Pavese N; Eunson L; Graham E; Lees AJ; Quinn NP; Wood NW; Brooks DJ; Piccini PP
    Brain; 2004 Jun; 127(Pt 6):1332-42. PubMed ID: 15090472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
    Ribeiro MJ; Thobois S; Lohmann E; du Montcel ST; Lesage S; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Broussolle E; Brice A; Remy P;
    J Nucl Med; 2009 Aug; 50(8):1244-50. PubMed ID: 19617340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy bodies and parkinsonism in families with parkin mutations.
    Farrer M; Chan P; Chen R; Tan L; Lincoln S; Hernandez D; Forno L; Gwinn-Hardy K; Petrucelli L; Hussey J; Singleton A; Tanner C; Hardy J; Langston JW
    Ann Neurol; 2001 Sep; 50(3):293-300. PubMed ID: 11558785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.
    Khan NL; Valente EM; Bentivoglio AR; Wood NW; Albanese A; Brooks DJ; Piccini P
    Ann Neurol; 2002 Dec; 52(6):849-53. PubMed ID: 12447943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
    Scherfler C; Khan NL; Pavese N; Lees AJ; Quinn NP; Brooks DJ; Piccini PP
    Mov Disord; 2006 Jun; 21(6):783-8. PubMed ID: 16511856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations.
    Broussolle E; Lücking CB; Ginovart N; Pollak P; Remy P; Dürr A
    Neurology; 2000 Sep; 55(6):877-9. PubMed ID: 10994015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
    Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
    Ibáñez P; Lesage S; Lohmann E; Thobois S; De Michele G; Borg M; Agid Y; Dürr A; Brice A;
    Brain; 2006 Mar; 129(Pt 3):686-94. PubMed ID: 16401616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations.
    Lücking CB; Bonifati V; Periquet M; Vanacore N; Brice A; Meco G
    Neurology; 2001 Sep; 57(5):924-7. PubMed ID: 11552035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.